Biological effects of epidermal growth factor, with emphasis on the gastrointestinal tract and liver: An update

Hepatology

Volumn 9, Issue 1, 1989, Pages 126-138

  Marti, Ulrich ^a,b   Burwen, Susan Jo ^a,b   Jones, Albert L ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; DNA; EPIDERMAL GROWTH FACTOR; RNA;

BIOSYNTHESIS; HUMAN; LIVER CELL; PRIORITY JOURNAL; REVIEW;

AMINO ACID SEQUENCE; ANIMAL; BRUNNER'S GLANDS; EPIDERMAL GROWTH FACTOR; GASTROINTESTINAL SYSTEM; HUMAN; LIVER; LIVER REGENERATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; SALIVARY GLANDS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024543241     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.1840090122     Document Type: Article

References (228)

1. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the newborn animal
2. Epidermal growth factor. Nobel lecture
3. Hormonal stimulation of DNA synthesis in primary cultures of adult rat hepatocytes
4. Epidermal growth factor: its biologic and metabolic effects with emphasis on the hepatocyte
5. Epidermal growth factor and a new derivative. Rapid isolation procedures and biological and chemical characterization
6. Part I. Epidermal growth factor: chemical and biological characterization
7. Synthesis and storage of epidermal growth factor in submaxillary gland
8. Immunohistochemical localization of urogastrone to human duodenal and submandibular glands
9. Mouse epidermal growth factor: light and electron microscopic localization by immunocytochemical staining
10. Immunocytochemical localization of epidermal growth factor during the postnatal development of the submandibular gland of the mouse
11. Immunocytochemical localization of epidermal growth factor in the mouse submandibular gland
12. Immunohistochemical localization of epidermal growth factor in rat and human
13. Cellular localization of human epidermal growth factor
14. Epidermal growth factor: effects of androgens and adrenergic agents
15. Proliferation of the intestinal epithelium and of the regenerating liver with a deficiency of the epidermal growth factor
16. Renal origin of rat urinary epidermal growth factor
17. Immunocytochemical localization of human epidermal growth factor/urogastrone in several human tissues
18. Functional EGF receptors are present on mouse embryo tissues
19. Hormonal regulation of epidermal growth factor and protease in the submandibular gland of the adult mouse
20. Radioimmunoassay of epidermal growth factor
21. The mouse submandibular gland. An exocrine organ for growth factors
22. The effect of pro‐gestins on the submaxillary gland epidermal growth factor: demonstration of androgenic, synandrogenic and antiandrogenic action
23. Aggressive behaviour in mice provokes a marked increase in both plasma epidermal growth factor and renin
24. Adrenergic effects on secretion of epidermal growth factor from Brunner's glands
25. Exocrine secretion of epidermal growth factor from Brunner's glands. Stimulation by VIP and acetylcholine
26. Effect of vasoactive intestinal polypeptide and somatostatin on secretion of epidermal growth factor and bicarbonate from Brunner's glands
27. Homologous radioimmunoassay for human epidermal growth factor (urogastrone)
28. Detection of epidermal growth factor‐urogastrone and its receptor during fetal mouse development
29. Growth factor in development
30. Epidermal growth factor: location of disulfide bonds
31. Epidermal growth factor. Physical and chemical properties
32. The isolation of the urogastrone inhibitors of gastric acid secretion from human urine
33. Rat epidermal growth factor: complete amino acid sequence. Homology with the corresponding murine and human proteins; isolation of a form truncated at both ends with full in vitro biological activity
34. Purification and partial characterization of epidermal growth factor isolated from the male rat submaxillary gland
35. Quantitation of epidermal growth factor in the rat. Identification and partial characterization of duodenal growth factors
36. The structure and biosynthesis of epidermal growth factor precursor
37. Epidermal growth factor, its receptor, and related proteins
38. Mouse prepro‐epidermal growth factor synthesis by the kidney and other tissues
39. Epidermal growth factor: high and low molecular weight forms
40. Characterization of the high molecular weight form of epidermal growth factor
41. Modification of the epidermal growth factor affecting the stability of its high molecular weight complex
42. Isolation and structure of urogastrone and its relationship to epidermal growth factor
43. The primary structure of human urogastrone
44. Human epidermal growth factor: isolation and chemical and biological properties
45. Human urogastrone and mouse epidermal growth factor share a common receptor
46. 125I‐labeled epidermal growth factor to human fibroblasts
47. Insulin and epidermal growth factor: human fibroblast receptors related to deoxyribonucleic acid synthesis and amino acid uptake
48. Epidermal growth factor
49. Epidermal growth factor receptors
50. The oligosaccharide moities of the epidermal growth factor receptor in A‐431 cells. Presence of complex‐type N‐linked chains that contain terminal N‐acetylgalactosamine residues
51. Epidermal growth factor‐receptor‐protein kinase interaction. Co‐purification of receptor and epidermal growth factor‐enhanced phosphorylation
52. Molecular mechanism of mitogen action: processing of receptor induced by epidermal growth factor
53. Receptors for epidermal growth factor (urogastrone) and insulin in primary cultures of rat hepatocytes maintained in serum‐free medium
54. Purification of an active EGF‐receptor kinase with monoclonal anti‐receptor antibodies
55. Close similarity of epidermal growth factor and v‐erb‐B oncogene protein sequences
56. The erb B gene and the EGF receptor
57. A native 170,000 epidermal growth factor receptor‐kinase complex from shed plasma mem brane vesicles
58. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells
59. Glycosylation of the epidermal growth factor receptor in A‐431 cells. the contribution of carbo hydrate to receptor function
60. Post‐translational processing of the epider mal growth factor receptor. Glycosylation‐dependent acquisition of ligand‐binding capacity
61. Biosynthesis and metabolic degra dation of receptors for epidermal growth factor
62. Insulin: in search of a mechanism
63. Molecular analysis of signal transduction by growth factors
64. The epidermal growth factor receptor as a multi functional allosteric protein
65. ATP‐stimulated interaction between epidermal growth factor receptor and supercoiled DNA
66. Effect of Triton X‐100 on insulin and epidermal growth factor receptor binding and autophosphorylation in Golgi fractions and partially purified receptors from rat liver
67. Solubilization of EGF receptor with Triton X‐100 alters stimulation of tyrosine residue phosphorylation by EGF and dimethyl sulfoxide
68. Epidermal growth factor: receptor in human fibroblasts and modulation of action by cholera toxin
69. Epidermal and nerve growth factors in mam malian development
70. Binding, internalization and degradation of epidermal growth factor by BALB 3T3 and PB 3T3 cells: relationship to cell density and the stimulation of cell proliferation
71. Biologically active phorbol esters specifically alter affinity of epidermal growth factor
72. Inhibition of epidermal growth factor binding to surface receptors by tumor promoters
73. The effects of sodium butyrate on epidermal growth factor binding to human cultured cancer cells (Abstract)
74. Down‐regulation of epidermal growth factor receptors in mouse embryos
75. Mitogenic response to epidermal growth factor: relationship to number, affinity, and down regulation of EGF receptors in three murine embryo lines
76. Resolution of high and low affinity epidermal growth factor receptors. Inhibition of high affinity component by low temperature, cylcloheximide, and phorbol es ters
77. Phorbol esters induce transient internalization without degradation of unoccupied epi dermal growth factor receptors
78. Epidermal growth factor: morphological demonstration of binding, internalization and ly sosomal association in human fibroblasts
79. Epidermal growth factor: relationship between receptor regulation and mitogenesis in 3T3 cells
80. Part II. Recent studies on the chemistry and biology of epidermal growth factor
81. Factors involved in the modulation of cell proliferation in vivo and in vitro: the role of fibroblast and epidermal growth factors in the proliferative response of mámmalian cells
82. Physiological and possible clinical significance of epidermal and nerve growth factors
83. Role of epidermal growth factor in embryonic devel opment
84. The epidermal growth factor (EGF)
85. Epidermal growth factor and its receptor
86. The effect of epider mal growth factor on neonatal incisor differentiation in the mouse
87. Epidermal growth factor‐induced precocious incisor eruption is associated with decreased tooth size
88. The effect of EGF on fetal lamb lung maturation (Abstract)
89. Effect of epider mal growth factor on lung maturation in fetal rabbits
90. EGF: receptor interactions and the stim ulation of cell growth
91. Hormonal regulation of orni‐thine decarboxylase and polyamines in primary cultured rat hep‐atocytes–differences in hormonal response between adult and fetal hepatocytes
92. Epidermal growth factor stimulation of ornithine decarboxylase activity in a human hepatoma cell line
93. Epidermal growth factor stimulates ornithine decarboxylase activity in the digestive tract of mouse (40357)
94. Epidermal growth factor. IV. The induction of ornithine decarboxylase
95. Modulation of γ‐gluta‐myltranspeptidase in normal rat hepatocytes in culture by cell density, epidermal growth factor and agents which alter cell differentiation
96. Epidermal growth factor and the multi plication of cultured human keratinocytes
97. Control of a cell surface major glycoprotein by epidermal growth factor
98. Effect of epidermal growth factor on collagen formation in liver‐derived epithelial clone cells
99. Epidermal growth factor stimulates collagen synthesis in liver‐derived epithelial clone cells
100. Characterization and regen eration of receptors for epidermal growth factor in mouse calvaria
101. Epidermal growth factor stimulates pros‐taglandin production and bone resorption in cultured mouse cal varia
102. Epidermal growth factor stimulates secretion of human chorionic gonadotropin by cultured human choriocarcinoma cells
103. Epidermal growth factor and expression of specific genes: effects on cultured rat pituitary cells are dissociable from mitogenic response
104. Inhibition of ovarian and testicular steroidogenesis by epidermal growth factor
105. Stimulation of adrenal cortisol biosyn thesis by epidermal growth factor
106. In vitro cardiovascular, renal and endocrine effects of epidermal growth factor in sheep (Abstract)
107. Treatment of ewes at different stages of pregnancy with epidermal growth factor: effects on wool growth and plasma concentration of growth hormone, prolactine, placental lactogen and thyroxine and on foetal devel opment
108. Epidermal growth factor: effect on circulating thyroid hormone levels in sheep
109. Thyroid hormone regulation of epidermal growth factor receptor levels in mouse mammary glands
110. Epidermal growth factor enhancement of skin tumor induction in mice
111. Growth‐inhibitory effects of epidermal growth factor and overexpression of its receptors on human squamous cell carcinomas in culture
112. Effects of epidermal growth factor receptor concentration on tumorigenicity of A431 cells in nude mice
113. EGF induces cell cycle arrest of A431 human epidermoid carcinoma cells
114. Characteristics and hormonal regulation of amino acid transport system A in isolated rat hepatocytes
115. EGF inhibits glucagon stimu lation of amino acid transport in primary cultures of adult rat hepatocytes
116. Mechanism of the inhibitory effect of EGF on cAMP‐stimulated amino acid transport
117. Epidermal growth factor, like glucagon, exerts a short‐term stimulation of alanine transport in rat hepa tocytes
118. + exchange by epidermal growth factor and vanadate in A431 cells is independent of phosphatidylinositol turnover and is inhibited by phorbol ester and diacylglycerol
119. + uptake in A431 cells
120. Effects of growth factors on intracellular pH regulation
121. The epidermal growth factor‐induced calcium signal in A431 cells
122. Some mitogens cause rapid increases in free calcium in fibroblasts
123. Pertussis toxin or phorbol 12‐myristate 13‐acetate can distinguish between epider mal growth factor‐ and angiotensin‐stimulated signals in hepa‐tocytes
124. Stimulation of sugar uptake in cultured fibroblasts by epidermal growth factor (EGF) and EGF‐binding arginine esterase
125. Epidermal growth factor stimulates monovalent cation transport in isolated rat hepato‐ cytes
126. Enhancement of calcium uptake and phos‐ phatidylinositol turnover by epidermal growth factor in A‐431 cells
127. Effect of 12‐O‐tetradeca‐ noylphorbol‐13‐acetate (TPA) on the growth inhibitory and in creased phosphatidylinositol (PI) responses induced by epidermal growth factor (EGF) in A431 cells
128. Epidermal growth factor stimulates the production of phosphatidylinositol monophosphate and the breakdown of polyphosphoinositides in A431 cells
129. Epidermal growth factor stimulates the rapid accumulation of inositol (1,4,5)‐tris‐phosphate and a rise in cytosolic calcium mobilized from intra cellular stores in A431 cells
130. 2+ in a human hepatocellular carcinoma‐derived cell line
131. Phosphatidylinositol kinase is activated in membranes derived from cells treated with epidermal growth factor
132. Calcium‐mobilizing receptors, polyphosphoino sitides, and the generation of second messengers
133. Epidermal growth factor (EGF) stimulates inositol trisphosphate formation in cells which overexpress the EGF receptor
134. Insulin and epidermal growth factor do not affect phosphoinositide metabolism in rat liver plasma membranes and hepatocytes
135. Effect of EGF and thombin on inositol‐containing phospholipids of cultured fibroblasts: stimu lation of phosphatidylinositol synthesis by thrombin but not EGF
136. EGF and insulin action in fibroblasts. Evidence that phosphoinositide hydrolysis is not an essential mitogenic signalling pathway
137. Lack of association of epidermal growth factor‐, insulin‐, and serum‐induced mitoge‐nesis with stimulation of phosphoinositide degratation in BALB/ c3T3 fibroblasts
138. Stimulation by epidermal growth factor of phospholipid methyltransferase in isolated rat hepato cytes
139. Rapid enhancement of protein phosphorylation in A‐431 cell membrane preparations by epider mal growth factor
140. Characterization by electro‐ phoresis of epidermal growth factor stimulated phosphorylation using A‐431 membranes
141. Quantitation of epidermal growth factor in the rat. Identification and partial characterization of duodenal EGF
142. Circadian stage‐dependent effects of epidermal growth factor on deoxyribonucleic acid syn thesis in ten different organs of the adult male mouse
143. Circadian phase‐dependent stimulatory effects of epidermal growth factor on deoxyribonucleic acid synthesis in the duodenum, jejunum, ileum, caecum, colon, and rectum of the adult male mouse
144. Chronobiology of the intes tinal tract of the mouse
145. Role of subman‐dibular saliva and epidermal growth factor in gastric cytoprotec‐tion
146. Cytoprotective effect of pentagastrin and epidermal growth factor on stress ulcer formation. Possible role of somatostatin
147. Effects of epider mal growth factor on gastrointestinal secretions
148. Epidermal growth factor inhibits cysteamine‐induced duodenal ulcers
149. Effect of urogastrone on gastric secretion and serum gastrin concentration in patients with duodenal ulceration
150. Intravenous but not intragastric urogastrone‐EGF is trophic to the intestine of par‐ enterally fed rats
151. Hypersecretion of submandibular saliva in male mice: trophic response in small intestine
152. Effect of mouse epidermal growth factor/urogastrone on the functional maturation of rat intestine
153. Interaction of epidermal growth factor with specific binding sites of enterocytes isolated from rat small intestine during development
154. Development of enteropeptidase activity in mouse small intestine: influence of hormones
155. Epidermal growth factor (EGF) accelerates the maturation of fetal mouse intestinal mucosa in utero
156. Effect of epidermal growth factor on the development of rat gastric mucosa
157. Influence of epidermal growth factor on the maturation of the fetal mouse duodenum in organ culture
158. Effects of epidermal growth factor (EGF) on adult mouse small intestine in vivo and in organ culture
159. Effects of intraluminal epidermal growth factor on mucosal proliferation in the small intestine of adult rats
160. The effect of epidermal growth factor (EGF) on cell proliferation of the gastrointestinal mucosa in rodents
161. Epidermal growth factor is a major growth factor in human milk
162. Concentration of epidermal growth factor and submandibular gland renin in male and female mouse tissue and fluids
163. Enhancement of intestinal growth in neonatal rats by epidermal growth factor in milk
164. Effect of urogastrone on gastric secretion and plasma gastrin levels in normal subjects
165. Effect of urogastrone in the Zollinger‐Ellison syndrome
166. Role of mucosal prostaglandins and DNA synthesis in gastric cytoprotection by luminal epidermal growth factor
167. Gastric cytoprotec tion by epidermal growth factor. Role of endogenous prostaglan dins and DNA synthesis
168. Salivary immunoreactive human epidermal growth factor (IR‐hEGF) in patients with peptic ulcer disease
169. Quantitative aspects of the effects of insulin, epidermal growth factor and dexamethasone on DNA synthesis in cultured adult rat hepatocytes
170. Epidermal growth factor stimulates proliferation of rat hepatoma cells producing alpha‐fetoprotein
171. Epidermal growth factor stimulates serine and tyrosine phosphorylation in a 59‐kD protein in purified plasma membranes from rat liver
172. Rat liver membranes contain a 120 kDa glycoprotein which serves as a substrate for the tyrosine kinase of the receptors for insulin and epidermal growth factor
173. The induction of fatty liver in neonatal animals by a purified protein (EGF) from mouse submaxillary gland
174. Epidermal growth factor enhances guanylate cyclase activity in vivo and in vitro
175. Epidermal growth factor mimics insulin effects in rat hepatocytes
176. Production of soma‐ tomedin‐like activity by human adult tumor derived, transformed and normal cell cultures and by cultured rat hepatocytes: effect of culture conditions and epidermal growth factor (urogastrone)
177. Characterization of hepatic epidermal growth factor receptor in the developing rat
178. Effect of epidermal growth factor on growth and postnatal development of the rabbit liver
179. Hormonal factors concerned with liver regeneration
180. Gut‐derived endotoxin elicits hepatotrophic factor secretion for liver regeneration
181. Hepatic sequestration and biliary secretion of epidermal growth factor: evidence for a high‐capacity uptake system
182. Kinetic analysis of hepatic regeneration
183. 3
184. Epidermal growth factor receptor number decreases during rat liver regeneration
185. Characterization and repartition of epidermal growth factor‐urogastrone receptor in gastric glands isolated from young and adult guinea pigs
186. Demon stration of specific receptors for EGF‐urogastrone in isolated rat intestinal epithelial cells
187. Peptide binding to intestinal epithelium: distinct sites for insulin, EGF and VIP
188. Functional receptors for epidermal growth factor in an epithelial‐cell line derived from the rat small intestine
189. Epidermal growth factor receptors in isolated adult mouse intestinal cells: studies in vivo and in organ culture
190. Epidermal growth factor: effect on the growth of human colon adenocarcinoma cell line (Abstract)
191. Human pancreatic cancer cells possess a glycoprotein epidermal growth factor receptor (Abstract)
192. Human esophageal carcinoma cells have fewer, but higher affinity epidermal growth factor receptors
193. Receptor‐mediated endocytosis of epi dermal growth factor by hepatocytes in the perfused rat liver: ligand and receptor dynamics
194. Receptor‐mediated endo cytosis of epidermal growth factor by rat hepatocytes: receptor pathway
195. Kinetics of epidermal growth factor binding and processing in isolated intact rat hepatocytes. Dynamic externalization of receptors during ligand internalization
196. Distribution of epidermal growth factor binding sites in the adult rat liver
197. On the uptake of materials by the intact liver: the transport and net removal of galactose
198. Autoradiographic evidence for hepatic lobular concentration gradient of bile acid derivative
199. Asialoorosomucoid hep‐ atobiliary transport is unaltered by the loss of liver asialoglyco‐ protein receptors in aged rats
200. 125 I‐insulin
201. Evidence for vesicular transport mechanism in hepatocytes for biliary secretion of immunoglobulin A
202. Autoradiographic localiza tion of the sites of uptake, cellular transport, and catabolism of low density lipoproteins in the liver of normal and estrogen‐treated rats
203. Transit of epidermal growth factor and transferrin through clathrin‐coated pits. Analysis of the kinetics of receptor entry
204. Direct visual ization of binding, aggregation and internalization of insulin and epidermal growth factor on living fibroblastic cells
205. 125 I‐labeled human epidermal growth fac‐tor. Binding, internalization, and degradation in human fibro‐blasts
206. Collection of insulin, EGF and alpha 2‐macroglobulin in the same patches on the surface of cultured fibroblasts and common internalization
207. Perinuclear location and recycling of epidermal growth factor receptor kinase: Immu‐nofluorescent visualization using antibodies directed to kinase and extracellular domains
208. Transport of epidermal growth factor by rat liver: evidence for a nonlysosomal pathway
209. Down regulation of epidermal growth factor receptors: direct demonstration of receptor degradation in human fibroblasts
210. Resolution of multiple endosomal com partments associated with the internalization of epidermal growth factor and transferrin
211. Proteolytic proc‐essing of epidermal growth factor within endosomes
212. Translocation of epider mal growth factor to the hepatocyte nucleus during rat liver regeneration
213. 125 I‐epidermal growth factor (EGF) (Abstract)
214. Nuclear accumulation of epidermal growth factor in cultured bovine corneal endothelial and granulosa cells
215. 125I] epidermal growth factor in rat epidermis and hair follicles: accumulation of nuclear label
216. Comparison of nuclear EGF binding protein from normal and regenerating liver with the EGF receptor (Abstract)
217. Early signals in the mitogenic response
218. Size heterogeneity of epidermal growth factor in human body fluids
219. Homologous radio immunoassay for epidermal growth factor in human saliva
220. Urogastrone‐epi‐dermal growth factor concentrations in prostatic fluid of normal individuals and patients with benign prostatic hypertrophy
221. Epidermal growth factor in human seminal plasma
222. Radioreceptor assay for epidermal growth factor
223. Epidermal growth factor in cow's milk and milk formulas
224. Plasma concentrations of immunoreactive human epidermal growth factor (urogastrone) in man
225. Enzyme‐linked immunosorbent assay (ELISA) for human epidermal growth factor (hEGF)
226. Epidermal growth factor and nerve growth factor in mouse saliva: a comparative study
227. Circadian phase‐dependent stimulation effects of epidermal growth factor on DNA synthesis in the tongue, esophagus and stomach of the adult male mouse
228. The human LDL receptor: a cysteine‐rich protein with multiple Alu sequences in its mRNA